Drug Type Monoclonal antibody |
Synonyms AER 004 |
Target |
Mechanism SARS-CoV-2 S protein inhibitors(Coronavirus spike glycoprotein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Aerium Therapeutics, Inc.Startup |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Preclinical | US | 04 Oct 2023 | |
COVID-19 | Preclinical | US | Aerium Therapeutics, Inc.Startup | 04 Oct 2023 |